These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 11332612
1. Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma. Asp J, Inerot S, Block JA, Lindahl A. J Orthop Res; 2001 Jan; 19(1):149-54. PubMed ID: 11332612 [Abstract] [Full Text] [Related]
2. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J. Cancer Res; 1996 Dec 01; 56(23):5475-83. PubMed ID: 8968104 [Abstract] [Full Text] [Related]
3. [The expression of p16, CDK4 and pRb in hepatocellular carcinomas]. Luo D, Liu Q, Su J. Zhonghua Gan Zang Bing Za Zhi; 1999 Jun 01; 7(2):94-5. PubMed ID: 10488417 [Abstract] [Full Text] [Related]
4. Alteration of pRb/p16/cdk4 regulation in human osteosarcoma. Benassi MS, Molendini L, Gamberi G, Ragazzini P, Sollazzo MR, Merli M, Asp J, Magagnoli G, Balladelli A, Bertoni F, Picci P. Int J Cancer; 1999 Oct 22; 84(5):489-93. PubMed ID: 10502725 [Abstract] [Full Text] [Related]
5. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Geradts J, Kratzke RA, Niehans GA, Lincoln CE. Cancer Res; 1995 Dec 15; 55(24):6006-11. PubMed ID: 8521382 [Abstract] [Full Text] [Related]
6. [The effects of exogenous p16 expression on CDK4, Cyclin D1 and pRb in nasopharyngeal carcinoma cell lines]. Zhao XR, Deng L, Weng XX. Hunan Yi Ke Da Xue Xue Bao; 2000 Oct 28; 25(5):428-30. PubMed ID: 12212108 [Abstract] [Full Text] [Related]
7. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN. Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755 [Abstract] [Full Text] [Related]
8. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B, Windhager R, Gadner H. Oncogene; 1997 Oct 01; 15(18):2225-32. PubMed ID: 9393981 [Abstract] [Full Text] [Related]
9. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H. Cancer Res; 1997 Oct 15; 57(20):4608-14. PubMed ID: 9377576 [Abstract] [Full Text] [Related]
10. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations. Nielsen GP, Burns KL, Rosenberg AE, Louis DN. Am J Pathol; 1998 Jul 15; 153(1):159-63. PubMed ID: 9665476 [Abstract] [Full Text] [Related]
11. Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma. Yao J, Pollock RE, Lang A, Tan M, Pisters PW, Goodrich D, El-Naggar A, Yu D. Clin Cancer Res; 1998 Apr 15; 4(4):1065-70. PubMed ID: 9563903 [Abstract] [Full Text] [Related]
12. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features. Semczuk A, Miturski R, Skomra D, Jakowicki JA. Arch Gynecol Obstet; 2004 Jan 15; 269(2):104-10. PubMed ID: 14648178 [Abstract] [Full Text] [Related]
13. Variable expression of p16 protein in patients with acute myeloid leukemia without gross rearrangements at the DNA level. Jamal R, Thomas NS, Gale RE, Linch DC. Leukemia; 1996 Apr 15; 10(4):629-36. PubMed ID: 8618439 [Abstract] [Full Text] [Related]
14. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M. Br J Cancer; 1999 Apr 15; 80(1-2):79-86. PubMed ID: 10389982 [Abstract] [Full Text] [Related]
15. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. Maelandsmo GM, Flørenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Børresen AL, Fodstad O. Br J Cancer; 1996 Apr 15; 73(8):909-16. PubMed ID: 8611425 [Abstract] [Full Text] [Related]
16. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Jarrard DF, Sarkar S, Shi Y, Yeager TR, Magrane G, Kinoshita H, Nassif N, Meisner L, Newton MA, Waldman FM, Reznikoff CA. Cancer Res; 1999 Jun 15; 59(12):2957-64. PubMed ID: 10383161 [Abstract] [Full Text] [Related]
17. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas. Tsuzuki T, Tsunoda S, Sakaki T, Konishi N, Hiasa Y, Nakamura M. Cancer; 1996 Jul 15; 78(2):287-93. PubMed ID: 8674005 [Abstract] [Full Text] [Related]
18. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Li Y, Nichols MA, Shay JW, Xiong Y. Cancer Res; 1994 Dec 01; 54(23):6078-82. PubMed ID: 7954450 [Abstract] [Full Text] [Related]
19. HPV infection and the alterations of the pRB pathway in oral carcinogenesis. Lim KP, Hamid S, Lau SH, Teo SH, Cheong SC. Oncol Rep; 2007 Jun 01; 17(6):1321-6. PubMed ID: 17487385 [Abstract] [Full Text] [Related]
20. Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells. Craig C, Kim M, Ohri E, Wersto R, Katayose D, Li Z, Choi YH, Mudahar B, Srivastava S, Seth P, Cowan K. Oncogene; 1998 Jan 15; 16(2):265-72. PubMed ID: 9464545 [Abstract] [Full Text] [Related] Page: [Next] [New Search]